Mortality for myocardial infarction is at its lowest historical level for 20 years, but comorbidities such as anemia, renal failure and hyperglycemia seem the next frontier to investigate their impact as risk modifiers mortality in acute myocardial infarction. Stress hyperglycemia is a very frequent problem in STEMI, but continuous insulin infusion therapy (CIIT) resulted in >threefold and >twofold increased risks in-hospital and 1-year mortality, respectively.
© 2019 The Authors. Endocrinology, Diabetes & Metabolism published by John Wiley & Sons Ltd.